Evidence map›Paper›PMID 33328533›Full record

ArticleScientific reports2020

Dynamic profiles of SARS-Cov-2 infection from five Chinese family clusters in the early stage of the COVID-19 pandemic.

Xiang-Gen Kong, Jin Geng, Tao Zhang, Bin Wang, An-Zhao Wu, Di Xiao, Zhao-Hua Zhang, Cai-Feng Liu, Li Wang, Xue-Mei Jiang and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiang-Gen KongJinan Infectious Diseases Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
Jin GengJinan Infectious Diseases Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
Tao ZhangDepartment of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Bin WangJinan Infectious Diseases Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
An-Zhao WuJinan Infectious Diseases Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
Di XiaoJinan Infectious Diseases Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
Zhao-Hua ZhangJinan Infectious Diseases Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
Cai-Feng LiuJinan Infectious Diseases Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
Li WangJinan Infectious Diseases Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China.
Xue-Mei JiangJinan Infectious Diseases Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong, China. shdjxm@163.com.
Yu-Chen FanDepartment of Hepatology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Wenhuaxi Road 107#, Jinan, 250012, China. fanyuchen@sdu.edu.cn.

Funding

China Postdoctoral Science Foundation 2020M672074National Natural Science Foundation of China 81970522Shandong University multidisciplinary research and innovation team of young scholars 2020QNQT11the Key Research and Development Project of Shandong Province 2019GSF108023the Science and Technology Development Plan Project of Jinan Health Committee 2020-1-2
6 · The paper itself

Abstract

Although several cases of family clusters with SARS-Cov-2 infection have been reported, there are still limited data preventing conclusions from being drawn regarding the characteristics and laboratory findings in the COVID-19 population within family clusters. In the present study, we retrospectively collected five family clusters with COVID-19 and summarized the dynamic profiles of the clinical characteristics, laboratory findings, immune markers, treatment and prognosis of this population. Furthermore, we also compared clinical and laboratory data between the SARS-Cov-2 infection with family cluster (n = 21) and those without family cluster (n = 16). We demonstrated that the duration of SARS-Cov-2 replication might be varied based on the different family clusters due to their different genetic backgrounds. The onset improved lung radiology might start at the end of the SARS-Cov-2 positive period. Furthermore, the obtained results demonstrated that similar basic characteristics and clinical findings seem to exist between the cases with SARS-Cov-2 and without family clusters. The serum level of ferritin might have a different biological function and be a new biomarker for the family cluster. Further studies with larger numbers of patients are required.

Indexed as

AdolescentAdultAgedAntiviral AgentsChild, PreschoolChinaCOVID-19FamilyFemaleHumansInfantMaleMiddle AgedPandemicsPrognosisRetrospective StudiesAntiviral Agents

Identifiers

PMID33328533
PMCPMC7744538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.